Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides …
Over the last 12 months, insiders at Haemonetics Corporation have bought $0 and sold $3.46M worth of Haemonetics Corporation stock.
On average, over the past 5 years, insiders at Haemonetics Corporation have bought $323,720 and sold $6M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $323,720 was made by ABERNATHY ROBERT E (director) on 2020‑08‑11.
2024-07-26 | Sale | President, Global Hospital | 4,312 0.0085% | $91.15 | $393,039 | -15.75% | ||
2024-07-12 | Sale | EVP, Chief Technology Officer | 79 0.0002% | $90.00 | $7,110 | 0.00% | ||
2024-07-11 | Sale | EVP, Chief Technology Officer | 2,136 0.0045% | $90.00 | $192,240 | 0.00% | ||
2024-05-29 | Sale | EVP and General Counsel | 12,990 0.0257% | $88.08 | $1.14M | -7.19% | ||
2024-05-29 | Sale | President, Global Hospital | 8,857 0.0174% | $87.53 | $775,253 | -7.19% | ||
2024-05-20 | Sale | EVP and General Counsel | 1,604 0.0032% | $95.08 | $152,508 | -13.65% | ||
2024-05-20 | Sale | EVP, Global Manufacturing | 987 0.0019% | $95.08 | $93,844 | -13.65% | ||
2024-05-20 | Sale | President, Global Hospital | 686 0.0013% | $95.11 | $65,245 | -13.65% | ||
2024-05-17 | Sale | EVP and General Counsel | 1,073 0.0021% | $95.00 | $101,935 | -13.71% | ||
2024-05-17 | Sale | EVP, Global Manufacturing | 822 0.0016% | $94.82 | $77,942 | -13.71% | ||
2024-05-16 | Sale | EVP and General Counsel | 985 0.002% | $96.14 | $94,698 | -12.57% | ||
2024-05-16 | Sale | EVP, Global Manufacturing | 770 0.0015% | $96.14 | $74,028 | -12.57% | ||
2024-05-16 | Sale | President, Global Hospital | 733 0.0015% | $96.04 | $70,397 | -12.57% | ||
2024-05-06 | Sale | EVP, Chief Technology Officer | 2,305 0.0045% | $95.00 | $218,975 | -12.54% | ||
2023-09-12 | Sale | President, Global Hospital | 228 0.0005% | $90.65 | $20,668 | -5.52% | ||
2023-09-11 | Sale | EVP, Chief Technology Officer | 2,305 0.0045% | $90.00 | $207,450 | -6.34% | ||
2023-09-05 | Sale | director | 10,215 0.0202% | $87.68 | $895,651 | -2.33% | ||
2023-07-18 | Sale | EVP, Global Manufacturing | 4,928 0.0095% | $90.00 | $443,520 | -6.13% | ||
2023-06-07 | Sale | President, Global Hospital | 2,538 0.005% | $88.04 | $223,446 | -2.38% | ||
2023-05-30 | Sale | EVP, Chief Technology Officer | 2,304 0.0045% | $83.33 | $191,992 | +2.78% |
Simon, Christopher | President & CEO | 213724 0.4255% | $77.41 | 1 | 21 | +13.41% |
CONCANNON BRIAN | President & CEO | 147040 0.2928% | $77.41 | 8 | 57 | +8.69% |
GELBMAN RONALD G | director | 48384 0.0963% | $77.41 | 1 | 16 | +4.67% |
LINDOP CHRISTOPHER J | CFO & EVP Business Development | 45350 0.0903% | $77.41 | 12 | 15 | +4.66% |
ALLEN PETER M | President, Global Plasma | 34102 0.0679% | $77.41 | 20 | 22 | +7.23% |
Capital Research Global Investors | $569.69M | 13.13 | 6.67M | +2.32% | +$12.9M | 0.13 | |
BlackRock | $510.77M | 11.77 | 5.98M | -0.92% | -$4.75M | 0.01 | |
The Vanguard Group | $460.66M | 10.62 | 5.4M | -0.17% | -$766,357.65 | 0.01 | |
Wellington Management Company | $364.52M | 8.4 | 4.27M | +30.68% | +$85.59M | 0.06 | |
Neuberger Berman | $323.28M | 7.45 | 3.79M | +7.28% | +$21.93M | 0.27 |